Építés alatt – nem éles oldal
Belépés
Résztvevőt keresFázis nélkül

Image-Based Prediction of Ventricular Tachycardias in Post-Myocarditis Patients: an International Multicenter Case-control Study

A legfontosabb adatok

Ki végzi
Centro Medico Teknon
Hol
Olaszország és Spanyolország3 helyszín, 2 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Toboroz
Résztvevők
150 fő, tervezett
Kezdés
2024. dec. 2.
Várható befejezés
2026. dec. 30.
A vizsgálat típusa
Megfigyeléses, 2 csoport
A regiszteradat frissítve
2024. december 12.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults who had myocarditis (inflammation of the heart muscle) more than 6 months ago. It studies whether heart MRI scar patterns can predict dangerous fast heart rhythms.

Életkor
Over 18 years.
Nem
All sexes can join.
A betegség stádiuma
Myocarditis diagnosed more than 6 months before joining. The myocarditis must no longer be active. A heart MRI (CMR) must have been done more than 6 months after diagnosis.

A részvétel fő kizáró okai

  • Pregnancy.
  • Other structural heart disease, such as congenital heart disease.
  • Active myocarditis, or myocarditis diagnosed less than 6 months ago.
  • Earlier documented sustained ventricular arrhythmias (lasting fast heart rhythms from the lower heart chambers).
  • Not able to have a contrast heart MRI (LGE-CMR), or taking part in other studies of experimental treatments.

A regiszter feltételei, szó szerint

Mind a 13 feltétel megnézéseKevesebb

Ki vehet részt

  • Age > 18 years
  • Myocarditis diagnosis > 6 months before the inclusion in the study
  • Signed informed consent
  • CMR performed > 6 months after myocarditis diagnosis

Ki nem vehet részt

  • Other concomitant structural heart diseases (e.g. congenital, non-ischemic, etc.)
  • Previously documented sustained ventricular arrhythmias
  • Concomitant investigation treatments
  • Age < 18 years
  • Pregnancy
  • Active myocarditis
  • Myocarditis diagnosis < 6 months
  • Impossibility or contraindications to undergo LGE-CMR
  • Medical, geographical and social factors that make study participation impractical, and inability to give written informed consent. Patient's refusal to participate in the study

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

2 országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

Ventricular arrhythmias (VAs) are frequently associated with structural heart diseases (SHD) such as myocardial infarction, myocarditis, and non-ischemic cardiomyopathies. Myocardial fibrotic tissue plays a central role in the genesis and the maintenance of re-entrant VAs associated with post-myocarditis sequelae and late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) has proven to be a useful tool for the non-invasive characterization of the scarred tissue and the underlying arrhythmogenic substrate. Moreover, a post-processing imaging platform named ADAS 3D LV (ADAS3D Medical SL, Barcelona, Spain) allows to analyze the CMR-derived data and to characterize the scar architecture, differentiating between dense (scar core zone) and more diffuse (border zone [BZ]) fibrosis, and identifying the BZ channels (BZCs) that are strands of healthy myocardial tissue within zones of unexcitable tissue and connect areas of normal myocardium. It was described that BZCs could serve as slow-conducting reentrant pathways and are critical to entail VA in ischemic and non-ischemic heart disease. However, the pathophysiological role and the correlation between scar architecture and VAs in post-myocarditis patients is yet to be defined.

A teljes eredeti leírásKevesebb

To date, the standard-of-care evaluation for primary prevention implantable cardioverter-defibrillator (ICD) therapy is LVEF-based, leading to the fact that the contemporary rate of appropriated therapies is very low. Moreover, events may also occur in patients with normal to moderately depressed LVEF, which is particularly relevant, as it constitutes the most prevalent population of patients exposed to an increased risk of VAs. Multiple studies reported that LGE at CMR is a strong and specific predictor of VT occurrence and sudden death in post-myocarditis patients. There were reported cases in which even after the normalization of LVEF, the extension of LGE, the scar architecture, and the presence of BZCs at cMR analysis are determinants of the arrhythmic risk in post-myocarditis patients.

The Investigators sought to evaluate the usefulness of CMR-derived scar architecture analysis to predict the occurrence of VT events in an international, multicenter, case-control study on unselected post-myocarditis patients without previous arrhythmia evidence. Aim of the study is also to assess the net reclassification improvement (NRI) for the indication of primary prevention ICD implantation using CMR data and post-processing data as compared to LVEF-based indication

A vizsgálat 2 csoportja

  • Cases: patients with sudden cardiac death or sustained ventricular arrhythmias during the follow-up

    Inclusion criteria Patients will only be recruited if they fulfill ALL the inclusion criteria: 1. Age \> 18 years. 2. Myocarditis diagnosis \> 6 months before the inclusion in the study. 3. Signed informed consent. 4. CMR performed \> 6 months after myocarditis diagnosis Exclusion criteria Patients will be excluded if they meet ANY of the following exclusion criteria: * Age \< 18 years. * Pregnancy. * Other concomitant structural heart diseases (e.g. congenital, non-ischemic, etc.) * Active myocarditis * Myocarditis diagnosis \< 6 months * Previously documented sustained ventricular arrhythmias. * Impossibility or contraindications to undergo LGE-CMR. * Concomitant investigation treatments. * Medical, geographical and social factors that make study participation impractical, and inability to give written informed consent. Patient's refusal to participate in the study.

  • Controls:patients without sudden cardiac death or sustained ventricular arrhythmias during follow-up

    Patients will only be recruited if they fulfill ALL the inclusion criteria: 1. Age \> 18 years. 2. Myocarditis diagnosis \> 6 months before the inclusion in the study. 3. Signed informed consent. 4. CMR performed \> 6 months after myocarditis diagnosis Patients will be excluded if they meet ANY of the following exclusion criteria: * Age \< 18 years. * Pregnancy. * Other concomitant structural heart diseases (e.g. congenital, non-ischemic, etc.) * Active myocarditis * Myocarditis diagnosis \< 6 months * Previously documented sustained ventricular arrhythmias. * Impossibility or contraindications to undergo LGE-CMR. * Concomitant investigation treatments. * Medical, geographical and social factors that make study participation impractical, and

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Image-Based Prediction of Ventricular Tachycardia Events in Post-Myocarditis Patients: an International Multicenter Case-control Study
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2024. december 12.